| INTRODUCTION
The liver transplant community intermittently debates whether urgency-based or utility-based prioritization is a more appropriate framework for liver allocation; recently, the debate has been readdressed in the context of rethinking geographic disparities. Urgencybased allocation, according to the rule of rescue, prioritizes the waitlist candidate who is most likely to die without an organ. The current model for end-stage liver disease (MELD)-based allocation system in the US is by design urgency-based since the MELD score predicts waitlist mortality. [1] [2] [3] MELD-based allocation, however, has recently been scrutinized due to concern that high-risk candidates may not adequately maximize the overall survival benefit of a limited organ supply. [4] [5] [6] [7] [8] In an effort to optimize use of such a scare resource, utility-based If MELD was a reasonable predictor of survival benefit, no fundamental change to our allocation system would be required to feel comfortable that utility-based allocation is reflected. As such, a clear quantification of the net survival benefit associated with MELD at LT is necessary to understand the strengths of our current allocation model in comparison to other proposed or debated metrics. We used national registry data and generalized gamma parametric models 13 to quantify the survival benefit afforded by LT across various strata of candidate MELD score and organ quality. We hypothesized that MELD correlates with, and therefore, effectively predicts the survival benefit of LT, thus appropriately balancing both urgency and utility. 
| MATERIALS AND METHODS

| Data source
| Study population
We identified 119 055 active adult LT candidates between January were incorporated in the model. LT recipients contributed time at risk to the LTC group prior to LT and contributed time at risk to the LT group post-LT. Candidates who were removed from the waitlist for reasons other than LT were followed until death or administrative censoring at the end of the study. Candidates who received live donor liver transplants contributed time at risk to the LTC group prior to transplants and were censored at transplant.
| Survival benefit of liver transplantation: relative life expectancy
Generalized gamma models were used to determine the survival benefit of LT. The generalized gamma model is a parametric survival analysis model with three parameters (β, σ, λ). 13 The exponentiated coefficient β indicates the ratio of time to event (death in our study).
Thus, the generalized gamma models produce ratios of life expectancy with LT to life expectancy while remaining on the waitlist (relative life expectancy), ie: 
| Survival benefit of liver transplantation: life years gained
Using the predicted survival estimates, we then calculated the expected life years gained after receipt of an LT. This was performed across the aforementioned MELD categories for a reference transplant recipient: a 50-year-old, non-African-American male who was blood type O, had ESLD due to non-cholestatic cirrhosis, was privately insured, had no malignancy, and was a firsttime transplant recipient. To test the robustness of our findings, we also calculated the expected life years gained for a "higherrisk" transplant recipient: a 65-year-old, African-American male who was blood type O, had ESLD due to non-cholestatic cirrhosis, was non-privately insured, had no malignancy, and was a first-time transplant recipient.
expected post transplant life years expected waitlist life years
| Survival benefit of liver transplantation: life expectancy and life years gained based on organ quality
We used the Donor Risk Index (DRI) to determine organ quality of the transplanted livers. 15 We categorized transplanted livers into low (DRI ≤ 1.20), medium (DRI 1.20-1.57), and high DRI (DRI ≥ 1.57) tertiles and explored the association of MELD and survival benefit across these categories. Liver transplant recipients across DRI category were compared to LTCs as above. Additionally, we showed that candidates with MELD 11-15 had slight survival benefit (TR = 1.05 1.20 1.37 ; 0.2 life years gained) from LT.
| Sensitivity analysis
| RESULTS
| Study population
| Survival benefit of liver transplantation based on across-organ quality
However, survival benefit of LT for low MELD groups remains a controversial topic. Schaubel et al 6 demonstrated on average, a survival benefit for MELD ≥ 9, while another study from the same group 17 demonstrated that LT conferred significantly higher mortality risk for candidates with MELD < 15. As our study and Schaubel et al 18 presented, survival benefit for low MELD groups was associated with organ quality. Survival benefit for low MELD groups was reduced with higher DRI organs, however, it is unlikely that low MELD recipients will receive organ offers from anything other than higher DRI organs.
Additionally, the slight survival benefit seen might be due to selection bias. That is, the low MELD candidates who were transplanted may There were several limitations in our study. First, our study was limited by the follow-up time of our cohort, therefore, we were only able to quantify life years gained over 10 years posttransplant.
However, this is one of the longest follow-up periods reported in the literature that currently evaluates posttransplant life years gained. 6 Second, the generalized gamma parametric model has more assumptions for underlying hazard function than a semi-parametric model (eg, Cox model). Violation of the assumptions may lead to biased results. However, a study has validated the generalized gamma parametric model in a large liver transplant population 22 and we further confirmed the validity of the model in our population by comparing the observed and predicted survival. Finally, some important clinical information is not captured comprehensively for liver transplant candidates in national registry data (eg, hospitalization status). Hence, adjustment was limited to reliable information in registry data.
In this nationwide study of waitlist candidates and liver transplant recipients, we have shown that liver transplant recipients with higher MELD gain significant life years after transplantation in comparison to remaining on the waiting list, with those of the highest MELD gaining the most survival benefit from transplant. These findings persist regardless of donor organ quality. Our current MELD-based allocation system not only prioritizes the sickest but also correlates with life years gained after transplantation. Therefore, the current MELDbased allocation system accounts for both urgency and utility of liver transplantation.
